67457-994Level 3
Regadenoson (Regadenoson)
**Product type:** Human Prescription Drug
**Active ingredient:** REGADENOSON
**Strength:** .4 mg/5mL
**Dosage form:** Injection
**Route:** Intravenous
**Labeler:** Mylan Institutional LLC
**Marketing category:** ANDA (ANDA213856)
**Pharmacologic class:** Adenosine Receptor Agonists [MoA], Pharmacologic Cardiac Stress Test Agent [EPC]
GET
/api/v1/systems/ndc_fda/nodes/67457-994Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.